β-blockers in Heart Failure - Veterans Affairs

Use in patients with NYHA class IV (or more severe) HF ... an effect that was independent of treatment with an angiotensin-converting enzyme inhibitor.37 The Carvedilol Post-Infarct Survival Control in LV Dysfunction (CAPRICORN) trial randomized 1959 patients with a LVEF < 40% post-MI (3 to 21 days) to carvedilol or placebo. ... ................
................